<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03256773</url>
  </required_header>
  <id_info>
    <org_study_id>F160125001</org_study_id>
    <nct_id>NCT03256773</nct_id>
  </id_info>
  <brief_title>High Resolution Micro OCT Imaging</brief_title>
  <official_title>Imaging of Human Epithelial Airway Using a High Resolution Micro OCT Catheter (Functional Anatomic Imaging of CF Patients With Early Lung Disease Using Micro OCT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn about using the imaging to make images of the lungs and
      nose with the long-term goal of the research leading to potential treatments and new
      therapies for patients with cystic fibrosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lung Disease is the predominate cause of morbidity and mortality in patients with cystic
      fibrosis (CF). A better understanding of the primary pathogenesis of CF is essential in order
      to reveal the features that may lead to the onset of progressive lung disease. Discerning the
      nature of the CF defect could resolve longstanding controversy and result in a new
      therapeutic opportunity that may address pathophysiology. Recently the investigators have
      developed an innovative technology, termed 1-µm resolution optical coherence tomography
      (µOCT), which enables real-time cross-sectional microscopy of the functional epithelial
      surface of living airways.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>feasibility of uOCT probe</measure>
    <time_frame>1 year</time_frame>
    <description>to determine if a uOCT probe can image airway epithelial cells from the lung and the nares of adult patients</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>COPD</condition>
  <condition>PCD - Primary Ciliary Dyskinesia</condition>
  <arm_group>
    <arm_group_label>Notmal</arm_group_label>
    <description>No lung Disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cystic Fibrosis</arm_group_label>
    <description>cystic fibrosis Lung Disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCD</arm_group_label>
    <description>Primary Ciliary Dyskinesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD</arm_group_label>
    <description>Chronic Obstructive Lung Disease</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Ten (10) adult subjects with CF and 10 without CF will be enrolled. Patients with COPD and
        PCD will also be recruited.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        THE INCLUSION CRITERIA:

          -  Patients diagnosed with CF or healthy normal controls with no respiratory disease

          -  Patients must be over the age of 18 but less than 70

          -  Patient must be able to give informed consent

        THE EXCLUSION CRITERIA:

          -  Patients with recent respiratory infection requiring antibiotics or corticosteroids in
             the last 4 weeks (excluding routine perioperative antibiotics)

          -  Patients with major sinus surgery that will alter the nasal anatomy and preclude
             imaging of the nares

          -  Any condition that in the opinion of the investigator will alter the safety of pilot
             testing in the operating room

          -  Female subjects who are pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Steven M Rowe</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heather Hathorne, PhD</last_name>
    <phone>205-638-9568</phone>
    <email>hhathorne@peds.uab.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ginger Reeves, BS</last_name>
    <phone>205-638-5970</phone>
    <email>greeves@peds.uab.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Hathorne, PhD</last_name>
      <phone>205-638-9568</phone>
      <email>hhathorne@peds.uab.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ginger Reeves, BS</last_name>
      <phone>205-638-5970</phone>
      <email>greeves@peds.uab.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Rowe Steven, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2017</study_first_submitted>
  <study_first_submitted_qc>August 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2017</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Steven M Rowe</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Dyskinesias</mesh_term>
    <mesh_term>Ciliary Motility Disorders</mesh_term>
    <mesh_term>Kartagener Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

